NCT01317394CompletedNot Applicable
Retrospective Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation
Taipei Medical University WanFang Hospital1 site in 1 country60 target enrollmentStarted: December 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 60
- Locations
- 1
Study Overview
Brief Summary
This study is a retrospective research in order to compare and analysis the risk factor, clinical manifestation and efficacy of albicans candidemia by pulling medical records. We hope that this retrospective research will let us understand the method of treatment and prevention of albicans candidemia in order to improve the quality of healthcare.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 20 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •above 20 years old
- •hospital patients
- •albicans candidemia patients
Exclusion Criteria
- •pregnant patients or patients under 16 years old
- •liver cirrhosis and Child C
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal InfectionsInvasive Fungal InfectionsNCT02678598Astellas Pharma China, Inc.2,555
Completed
Phase 2
Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute LeukemiaAcute LeukemiaNCT02440178Seoul National University Hospital66
Completed
Phase 1
Alternate Day Micafungin: A PK Study in Pediatric PatientsFungal InfectionNCT00842504Children's Hospital Medical Center, Cincinnati15
Terminated
Phase 2
Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for AspergillosisAspergillosisNCT00047827Astellas Pharma Inc2
Terminated
Phase 1
A Pharmacokinetic Study of Pediatric Micafungin ProphylaxisImmunocompromisedBone Marrow TransplantCancerNCT02057289Children's Hospital Medical Center, Cincinnati9